e-learning
resources
Berlin 2008
Monday, 06.10.2008
Smoking cessation and new tobacco uses
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Withdrawal symptoms in psychiatric patients treated with varenicline
N. Soureti, S. Vakali, A. Florou, D. Michailidis, K. Triviza, C. Roussos, C. Gratziou (Athens, Greece)
Source:
Annual Congress 2008 - Smoking cessation and new tobacco uses
Session:
Smoking cessation and new tobacco uses
Session type:
Thematic Poster Session
Number:
2075
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
N. Soureti, S. Vakali, A. Florou, D. Michailidis, K. Triviza, C. Roussos, C. Gratziou (Athens, Greece). Withdrawal symptoms in psychiatric patients treated with varenicline. Eur Respir J 2008; 32: Suppl. 52, 2075
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Static lung volumes and spirometry measurements
Panel discussion on Basic translational and clinical research – building a career in paediatric pulmonology- experiences from clinicians in lower middle income countries
Panel discussion: The role of pharmacotherapy connected to OSA pathophysiological traits
Related content which might interest you:
Influence of psychiatric disorders in patients treated with Varenicline.
Source: International Congress 2017 – Smoking cessation treatment and e-cigarettes
Year: 2017
The effects of anxiety and depression on treatment adherence in COPD patients
Source: Annual Congress 2010 - COPD: systemic inflammation and comorbidities
Year: 2010
Problems of treatment of TB patients suffering from alcohol and drugs addiction
Source: Eur Respir J 2002; 20: Suppl. 38, 369s
Year: 2002
Effects of CPAP treatment on anxiety and depression in patients with OSAS
Source: International Congress 2017 – Efficacy of and compliance with obstructive sleep apnoea treatment
Year: 2017
Depressive symptoms in asthma patients
Source: Annual Congress 2012 - Asthma: assessment and treatment
Year: 2012
Clinical effectiveness of antidepressive drug in patients with COPD and concomitant moderate depressive episode
Source: Annual Congress 2013 –COPD treatment and others
Year: 2013
Enough is enough: misuse of NIV in the treatment of chronic patients with exacerbation of symptoms?
Source: Annual Congress 2013 –The dark side of the moon: when, why, and where I should not use NIV?
Year: 2013
Attitudes of patients with chronic breathlessness towards treatment with opioids
Source: Eur Respir J, 55 (2) 1901752; 10.1183/13993003.01752-2019
Year: 2020
Acute psychosis after CPAP treatment in a schizophrenic patient with sleep apnoea{-}hypopnoea syndrome
Source: Eur Respir J 2001; 17: 313-315
Year: 2001
Impact of add-on medications on patient‘s satisfaction in patients with asthma
Source: Eur Respir J 2005; 26: Suppl. 49, 273s
Year: 2005
High prevalence of current smokers among COPD patients with anxiety and depression symptoms
Source: Eur Respir J 2001; 18: Suppl. 33, 193s
Year: 2001
Prevalence of psychiatric disorders in seriously-ill COPD patients
Source: Annual Congress 2008 - COPD epidemiology
Year: 2008
The efficacy and side-effects of varenicline in patients with pneumologic diseases
Source: Annual Congress 2009 - Smoking cessation
Year: 2009
Survey of dyspnoea in COPD patients on medication and preemptive use of a short-acting β-2 agonist
Source: Annual Congress 2009 - Drug effects in COPD
Year: 2009
Nurse-led cognitive behavioural therapy for treatment of anxiety in COPD
Source: ERJ Open Res, 4 (4) 00221-2018; 10.1183/23120541.00221-2018
Year: 2018
Patients with moderate asthma symptoms may benefit from short-term inhaled corticosteroid monotherapy
Source: Eur Respir J 2007; 30: Suppl. 51, 615s
Year: 2007
Opioid prescription for severe chronic breathlessness to hospitalised patients with COPD - a clinical audit
Source: Virtual Congress 2020 – Clinical data and COPD management
Year: 2020
GERD and anxiety in patients with severe COPD
Source: Annual Congress 2011 - COPD mechanisms
Year: 2011
Withdrawal of ICS in patients with COPD
Source: Virtual Congress 2020 – Pharmacological management of COPD
Year: 2020
Sleep disordered breathing in patients receiving therapy with buprenorphine/naloxone
Source: Eur Respir J 2013; 42: 394-403
Year: 2013
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept